Media Video VIDEO | Proactive Investors – March 2022 by scott forrest March 22, 2022 Orthocell Managing Director, Paul Anderson, spoke with Andrew Scott from Proactive Investors to discuss Australian regulatory (TGA) approval for our Remplir™ nerve repair device.
